News | April 25, 2023
Sun Pharma launches CEQUA, a novel therapy for Dry Eye Disease in India
CEQUA is the first dry eye treatment available in India that is delivered with nanomicellar (NCELL) technology
CEQUA is the first dry eye treatment available in India that is delivered with nanomicellar (NCELL) technology
The USFDA had classified the inspection as "Official Action Indicated" (OAI).
The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market
Agasta Software is engaged in research, development and commercialization of medical devices
The respective product approval is based on Revlimid Capsules, 5mg, 10mg, 15mg, 25mg and 2.5mg, 20mg as a reference product
India formulation sales at Rs. 3,391.9 crore, up 7.1% over Q3 last year
SEZABY is a benzyl alcohol-free and propylene glycol-free formulation of phenobarbital sodium powder for injection
Palbociclib has a unique mechanism of action which helps in delaying disease progression when co-administered with hormonal therapies
The Halol facility was placed under Import Alert by USFDA.
Subscribe To Our Newsletter & Stay Updated
